Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Integrated genetic, epigenetic, and immune landscape of T... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Integrated genetic, epigenetic, and immune landscape of TP53 mutant AML and higher risk MDS treated with azacitidine
0
Authors
Amer Zeidan
10 more
Amer Zeidan
•
Jan Bewersdorf
8 more
•
Brian Fox
Published
January 1, 2024
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to comment
Add a comment...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Therapeutic Advances in Hematology
Topics
Biology
Cancer Oncology
Medicine
Immunology
Internal Medicine
Show all topics
DOI
10.1177/20406207241257904
License
CC-BY-NC
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Therapeutic Advances in Hematology
Topics
Biology
Cancer Oncology
Medicine
Immunology
Internal Medicine
Show all topics
DOI
10.1177/20406207241257904
License
CC-BY-NC
